Teva Provides Update On Las Vegas Trial
Teva Pharmaceutical Industries Ltd. (Nasdaq:TEVA) announced today that a Las Vegas Jury awarded $356M in punitive damages against Teva Parenteral Medicines. Teva is reviewing the full judgment and continues to believe that the evidence shows the Company acted responsibly. The label for its propofol product clearly states that it is for single patient use only and that aseptic procedures should …